Myriam Riek

582 citations
12 papers · 457 indexed · h-index 10
Topics
HIV/AIDS drug development and treatment (4 papers)Rheumatoid Arthritis Research and Therapies (4 papers)HIV Research and Treatment (2 papers)

In The Last Decade

Myriam Riek

12 papers receiving 448 citations

Peers

Myriam Riek
Comparison fields: 5 of 61
  • Rheumatology 162
  • Oncology 138
  • Pulmonary and Respiratory Medicine 84
  • Infectious Diseases 80
  • Genetics 79
Replace Steven Jungerwirth with:
Steven Jungerwirth United States
Peter N. Morcos United States
Barbara J. Brennan United States
David L. Hyslop United States
Mathias Schneeweiss‐Gleixner Austria
Akshanth R. Polepally United States
Giulia Fornasier Italy
A. D. R. Huitema Netherlands
Caroline Berube United States
Laura C. Michaelis United States
Myriam Riek relative to Steven Jungerwirth United States Steven Jungerwirth's profile →
Citations per field
00.5×5.7×
Steven Jungerwirth · 1×
Citations per year

Countries citing papers authored by Myriam Riek

Since Specialization
Citations

This map shows the geographic impact of Myriam Riek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Riek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Riek more than expected).

Fields of papers citing papers by Myriam Riek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriam Riek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Riek. The network helps show where Myriam Riek may publish in the future.

Co-authorship network of co-authors of Myriam Riek

This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Riek. A scholar is included among the top collaborators of Myriam Riek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Riek. Myriam Riek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 6
3 69
4 43
5 52
6 9
7 44
8 12
9 18
10 77
11 108
12 17

About Myriam Riek

Myriam Riek is a scholar working on Virology, Infectious Diseases and Rheumatology, having authored 12 papers that have together received 457 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Rheumatology (162 citations), Genetics (79 citations) and Pharmacology (61 citations). Myriam Riek has collaborated with scholars based in Switzerland, United States and Norway. Frequent co-authors include Bert L. Lum, Ashok Rakhit, Scott Fettner, Axel Finckh, Almut Scherer, Cem Gabay, Christophe Schmitt, Hannah M. Jones, Michael Pantze and Marta Hamilton. Their work appears in journals such as Scientific Reports, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026